July 1, 2022
Loading...
You are here:  Home  >  Health Care & Life Science  >  Current Article

Amgen immunotherapies show positive results

IN THIS ARTICLE

Amgen released positive data for two immunotherapies in its BiTE platform, treating acute myeloid leukemia and multiple myeloma, the latter of which has been fast-tracked for development by the U.S. Food and Drug Administration. The Thousand Oaks-based biotech giant announced Dec. 3 that its AMG 420 and AMG 330 immunotherapies had both shown early evidence…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.